Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
30 employees
Viacor: Innovating catheter-based solutions for heart valve diseases and CHF.
HQ
Founded
1999
Viacor is a development stage company focused on pioneering catheter-based techniques for treating heart valve diseases that contribute to congestive heart failure (CHF). Their mission is to innovate medical devices and instruments that improve patient outcomes in the cardiovascular sector.
Viacor has made significant strides in developing advanced catheter-based solutions, positioning itself as a key player in the medical device industry. Their innovative approach has the potential to transform heart valve disease treatment, offering less invasive options for patients and healthcare providers.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Medical Devices
Technology
HealthTech, Biotech
Tags
Hardware
Model Types
Recurring
Revenue Type(s)
Healthcare
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Viacor founded?
Viacor was founded in 1999.
Where is Viacor's headquarters located?
Viacor's headquarters is located in Wilmington, MA, US.
When was Viacor's last funding round?
Viacor's most recent funding round was for $8.9M (USD) in November 2010.
How many employees does Viacor have?
Viacor has 30 employees as of Feb 5, 2024.
How much has Viacor raised to-date?
As of July 05, 2023, Viacor has raised a total of $34M (USD) since Nov 10, 2010.
Add Comparison
Total Raised to Date
$34M
USD
Last Update Nov 10, 2010
Last Deal Details
$8.9M
USD
Nov 10, 2010
Debt Financing
Current Employees
30
Last updated: Feb 5, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts